Ace Therapeutics is an innovative CRO company focusing in early drug discovery services from target validation to preclinical candidate identification and efficacy evaluation, with strong capabilities and technologies in the stroke field.
Our goal is to help pharmaceutical companies complete their research programs faster and more successfully, and find effective therapies for stroke.
View Details
Ace Therapeutics is committed to the preclinical phase of stroke drug development, covering everything from model construction, target identification to preclinical candidates and beyond with the flexibility required. We offer a broad portfolio of services and a global network of partners that enable us to provide end-to-end services for small molecule and biomolecule drug discovery in stroke.
Ischemic and hemorrhagic strokes exhibit neurological dysfunction due to various pathophysiological mechanisms, which provide you with reliable targets to seek more promising stroke treatments.
Ace Therapeutics has a proven, full-service model that has been delivering quality results for years, giving your stroke trial a competitive edge. The Ace Therapeutics team supports the development of therapeutics for the treatment of stroke through the use of our in-house resources including:
We are committed to accelerating progress in stroke research and drug development.